18 results
10-Q
2023 Q3
EX-3.1
SPRO
Spero Therapeutics Inc
Quarterly report
13 Nov 23
4:02pm
8-K/A
EX-3.1
SPRO
Spero Therapeutics Inc
16 Oct 23
Amendments to Articles of Incorporation or Bylaws
4:01pm
8-K
EX-3.1
SPRO
Spero Therapeutics Inc
10 Oct 23
Departure of Directors or Certain Officers
8:28am
8-K
EX-3.1
SPRO
Spero Therapeutics Inc
18 Aug 21
Departure of Directors or Certain Officers
4:48pm
8-K
EX-3.1
SPRO
Spero Therapeutics Inc
14 Sep 20
Entry into a Material Definitive Agreement
9:26am
8-K
EX-3.1
dlnq3
28 Feb 20
Material Modifications to Rights of Security Holders
4:31pm
8-K
EX-3.1
ccm 8gc1dsrm37x
16 Nov 18
Entry into a Material Definitive Agreement
9:01am
8-K
EX-3.1
8s4lg6 702bpoyiw
17 Jul 18
Amendments to Articles of Incorporation or Bylaws
4:31pm
8-K
EX-3.2
x0mfu4n wtcsn
6 Nov 17
Spero Therapeutics Announces Closing of Initial Public Offering
12:00am
8-K
EX-3.1
3545x61a6e6l
6 Nov 17
Spero Therapeutics Announces Closing of Initial Public Offering
12:00am
S-1/A
EX-3.2
util 3qgqcmh
23 Oct 17
IPO registration (amended)
12:00am
S-1/A
EX-3.5
kjbzzvh y75
23 Oct 17
IPO registration (amended)
12:00am
S-1/A
EX-3.3
en8a489ozjb9
23 Oct 17
IPO registration (amended)
12:00am
S-1
EX-3.1
wirlu
6 Oct 17
IPO registration
12:00am
S-1
EX-3.4
q9vh6s
6 Oct 17
IPO registration
12:00am
DRS
EX-3
y20f604357mt
25 Aug 17
Draft registration statement
12:00am
DRS
EX-3
yy5x qbwprcwanle2
25 Aug 17
Draft registration statement
12:00am
- Prev
- 1
- Next